Cargando…
Vascularized Composite Allotransplantation: Medical Complications
The objective of this review is to summarize the collective knowledge regarding the risks and complications in vascularized composite tissue allotransplantation (VCA), focusing on upper extremity and facial transplantation. The field of VCA has entered its second decade with an increasing experience...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101879/ https://www.ncbi.nlm.nih.gov/pubmed/32288984 http://dx.doi.org/10.1007/s40472-016-0113-x |
_version_ | 1783511713129168896 |
---|---|
author | Uluer, Mehmet C. Brazio, Philip S. Woodall, Jhade D. Nam, Arthur J. Bartlett, Stephen T. Barth, Rolf N. |
author_facet | Uluer, Mehmet C. Brazio, Philip S. Woodall, Jhade D. Nam, Arthur J. Bartlett, Stephen T. Barth, Rolf N. |
author_sort | Uluer, Mehmet C. |
collection | PubMed |
description | The objective of this review is to summarize the collective knowledge regarding the risks and complications in vascularized composite tissue allotransplantation (VCA), focusing on upper extremity and facial transplantation. The field of VCA has entered its second decade with an increasing experience in both the impressive good outcomes, as well as defining challenges, risks, and experienced poor results. The limited and selective publishing of negative outcomes in this relatively new field makes it difficult to conclusively evaluate outcomes of graft and patient survival and morbidities. Therefore, published data, conference proceedings, and communications were summarized in an attempt to provide a current outline of complications. These data on the medical complications of VCA should allow for precautions to avoid poor outcomes, data to better provide informed consent to potential recipients, and result in improvements in graft and patient outcomes as VCA finds a place as a therapeutic option for selected patients. |
format | Online Article Text |
id | pubmed-7101879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71018792020-03-31 Vascularized Composite Allotransplantation: Medical Complications Uluer, Mehmet C. Brazio, Philip S. Woodall, Jhade D. Nam, Arthur J. Bartlett, Stephen T. Barth, Rolf N. Curr Transplant Rep Vascularized Composite Allografts (L Cendales and R Barth, Section Editors) The objective of this review is to summarize the collective knowledge regarding the risks and complications in vascularized composite tissue allotransplantation (VCA), focusing on upper extremity and facial transplantation. The field of VCA has entered its second decade with an increasing experience in both the impressive good outcomes, as well as defining challenges, risks, and experienced poor results. The limited and selective publishing of negative outcomes in this relatively new field makes it difficult to conclusively evaluate outcomes of graft and patient survival and morbidities. Therefore, published data, conference proceedings, and communications were summarized in an attempt to provide a current outline of complications. These data on the medical complications of VCA should allow for precautions to avoid poor outcomes, data to better provide informed consent to potential recipients, and result in improvements in graft and patient outcomes as VCA finds a place as a therapeutic option for selected patients. Springer International Publishing 2016-08-15 2016 /pmc/articles/PMC7101879/ /pubmed/32288984 http://dx.doi.org/10.1007/s40472-016-0113-x Text en © Springer International Publishing AG 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Vascularized Composite Allografts (L Cendales and R Barth, Section Editors) Uluer, Mehmet C. Brazio, Philip S. Woodall, Jhade D. Nam, Arthur J. Bartlett, Stephen T. Barth, Rolf N. Vascularized Composite Allotransplantation: Medical Complications |
title | Vascularized Composite Allotransplantation: Medical Complications |
title_full | Vascularized Composite Allotransplantation: Medical Complications |
title_fullStr | Vascularized Composite Allotransplantation: Medical Complications |
title_full_unstemmed | Vascularized Composite Allotransplantation: Medical Complications |
title_short | Vascularized Composite Allotransplantation: Medical Complications |
title_sort | vascularized composite allotransplantation: medical complications |
topic | Vascularized Composite Allografts (L Cendales and R Barth, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101879/ https://www.ncbi.nlm.nih.gov/pubmed/32288984 http://dx.doi.org/10.1007/s40472-016-0113-x |
work_keys_str_mv | AT uluermehmetc vascularizedcompositeallotransplantationmedicalcomplications AT braziophilips vascularizedcompositeallotransplantationmedicalcomplications AT woodalljhaded vascularizedcompositeallotransplantationmedicalcomplications AT namarthurj vascularizedcompositeallotransplantationmedicalcomplications AT bartlettstephent vascularizedcompositeallotransplantationmedicalcomplications AT barthrolfn vascularizedcompositeallotransplantationmedicalcomplications |